PCC 2.22% 22.0¢ probiomics limited

future, page-3

  1. 14 Posts.
    Much appreciated, your information Ken.
    The company has a potentially exciting and financially rewarding product, if my reading of past company announcements is correct.
    Time and patience would also be a challege for holders of this stock.
    The stock at these levels would be worth a close look at. Minimal downside. Maybe plenty of blue sky, should there be positive good news.
    The health area is pretty important, for all of us.
 
watchlist Created with Sketch. Add PCC (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.